Showing results (301-310 of 9,050) with videos related to
Sort By:
Pageof 905
Rheumatology (Oxford, England)|February 9, 2022
Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphyBrittany Adler, Laura K Hummers, P Jay Pasricha, et al.Rheumatology (Oxford, England)|February 9, 2022
Non-criteria manifestations in the presence of antiphospholipid antibodies in a paediatric cohortPatricia Morán-Álvarez, África Andreu-Suárez, Liz Caballero-Mota, et al.Rheumatology (Oxford, England)|February 9, 2022
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaborationBénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, et al.Rheumatology (Oxford, England)|February 8, 2022
Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of IrelandHanna Lythgoe, Eve M D Smith, Orla G Killeen, et al.Rheumatology (Oxford, England)|February 12, 2022
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trialElizabeth R Volkmann, Michael Kreuter, Anna M Hoffmann-Vold, et al.Rheumatology (Oxford, England)|February 1, 2022
Pharmacological treatment in adult patients with CRPS-I: a systematic review and meta-analysis of randomized controlled trialsAngelo Fassio, Alessandro Mantovani, Davide Gatti, et al.Rheumatology (Oxford, England)|June 22, 2019
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fracturesGuido Nador, Karthik Ramasamy, Fotios Panitsas, et al.Rheumatology (Oxford, England)|February 22, 2022
Competitive binding of transcription factors underlies flexibility of T peripheral helper cells and T follicular helper cells in SLEQinglian Jiang, Jiakai Wang, Hongkun Jiang, et al.Rheumatology (Oxford, England)|February 24, 2022
Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseasesJoo Guan Yeo, Wan Ni Chia, Kai Liang Teh, et al.Rheumatology (Oxford, England)|June 12, 2019
Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trialSeung Cheol Shim, Ljubinka Božić-Majstorović, Alfredo Berrocal Kasay, et al.Pageof 905